Cargando…

Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection

Detalles Bibliográficos
Autores principales:	Fishbane, Steven, Hirsch, Jamie S., Nair, Vinay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the National Kidney Foundation, Inc. 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754454/ https://www.ncbi.nlm.nih.gov/pubmed/35032591 http://dx.doi.org/10.1053/j.ajkd.2022.01.001

Ejemplares similares

Editorial: Rebound COVID-19 and Cessation of Antiviral Treatment for SARS-CoV-2 with Paxlovid and Molnupiravir
por: Parums, Dinah V.
Publicado: (2022)

Risks of paxlovid in a heart transplant recipient
por: Stawiarski, Kristin, et al.
Publicado: (2023)

An explanation for SARS-CoV-2 rebound after Paxlovid treatment
por: Perelson, Alan S., et al.
Publicado: (2023)

Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection
por: Sun, Fangfang, et al.
Publicado: (2022)

Mathematical model of SARS-CoV-2 immunity predicts Paxlovid rebound
por: Ranard, Benjamin L., et al.
Publicado: (2023)

In Silico Evaluation of Paxlovid’s Pharmacometrics for SARS-CoV-2: A Multiscale Approach
por: Bartha, Ferenc A., et al.
Publicado: (2022)

Interactions of the Anti-SARS-CoV-2 Agents Molnupiravir and Nirmatrelvir/Paxlovid with Human Drug Transporters
por: Bakos, Éva, et al.
Publicado: (2023)

Special Issue: Advances in SARS-CoV-2 Infection
por: Contini, Carlo, et al.
Publicado: (2023)

A sustainable synthesis of the SARS-CoV-2 M(pro) inhibitor nirmatrelvir, the active ingredient in Paxlovid
por: Kincaid, Joseph R. A., et al.
Publicado: (2022)

SARS-CoV-2 Infection in the Heart Transplant Recipient
por: Shah, Jassim Zaheen, et al.
Publicado: (2020)

Case Report: tacrolimus toxicity in the setting of concurrent Paxlovid use in a heart-transplant recipient
por: Modi, Sujal, et al.
Publicado: (2023)

Special Issue “SARS-CoV-2: Epidemiology and Pathogenesis”: Editorial
por: Calistri, Paolo, et al.
Publicado: (2023)

Paxlovid with Caution: Novel Case of Paxlovid-Induced Tacrolimus Toxicity in a Cardiac Transplant Patient
por: Shah, Aaisha, et al.
Publicado: (2022)

Enabling liver transplantation during the COVID-19 era: More than screening donors and recipients for SARS-CoV-2
por: Abdala, Edson, et al.
Publicado: (2020)

New Insights Into SARS-CoV-2-specific Antibody Levels in Kidney Transplantation Recipients After Three Vaccination Doses
por: Kang, Hyunhye, et al.
Publicado: (2024)

Paxlovid (Nirmatelvir/Ritonavir) and Tacrolimus Drug-Drug Interaction in a Kidney Transplant Patient with SARS-2-CoV infection: A Case Report
por: Prikis, Marios, et al.
Publicado: (2022)

A 1-Pot Synthesis of the SARS-CoV-2 M(pro) Inhibitor Nirmatrelvir, the Key Ingredient in Paxlovid
por: Caravez, Juan C., et al.
Publicado: (2022)

Clinical efficacy analysis of paxlovid in children with hematological diseases infected with the omicron SARS-CoV-2 new variant
por: Li, Yixian, et al.
Publicado: (2023)

SARS-CoV-2 Sequel: Pulmonary Mucormycosis with a Mycotic Aneurysm in a Transplant Recipient
por: Dantis, Klein, et al.
Publicado: (2021)

The cardiac effects of SARS-CoV2: COVID-19 special issue
por: Camm, C Fielder, et al.
Publicado: (2020)

Special Issue “SARS-CoV-2 Innate and Adaptive Immune Responses”
por: Planes, Rémi, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Devresse, Arnaud, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients
por: Peghin, Maddalena, et al.
Publicado: (2022)

SARS-CoV-2 vaccine strategies in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2023)

Persistence of SARS-CoV-2 antibodies in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

The Path to Paxlovid
por: Halford, Bethany
Publicado: (2022)

Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient
por: Kwon, Eun-Jeong, et al.
Publicado: (2022)

Fatal SARS-CoV-2 infection in a renal transplant recipient
por: Dirim, Ahmet Burak, et al.
Publicado: (2020)

SARS-CoV-2 Re-Infection in a Lung Transplant Recipient
por: Buddhdev, B., et al.
Publicado: (2021)

Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients
por: Phadke, Varun K., et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 in Croatian solid-organ transplant recipients
por: Mrzljak, Anna, et al.
Publicado: (2021)

Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2021)

SARS-CoV-2 and Tacrolimus Blood Concentration in Kidney Transplant Recipients
por: McMinn, Jason, et al.
Publicado: (2021)

Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection
por: Weber, Sven C., et al.
Publicado: (2022)

Predictors of Nonseroconversion to SARS-CoV-2 Vaccination in Kidney Transplant Recipients
por: Frölke, Sophie C., et al.
Publicado: (2022)

Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination-Induced Immunogenicity in Heart Transplant Recipients
por: Memenga, Felix, et al.
Publicado: (2023)

Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients
por: Kared, Hassen, et al.
Publicado: (2023)

COVID 19, Paxlovid and the lesson from rare genetic diseases with naturally occurring protection from SARS-CoV-2 infection
por: Calò, Lorenzo A., et al.
Publicado: (2022)

The efficacy of paxlovid in elderly patients infected with SARS-CoV-2 omicron variants: Results of a non-randomized clinical trial
por: Zhong, Weijie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8pbg9u76d4egr6rk63qhce4p5r